Patients' and Providers' Views on Optimal Evidence-Based and Scalable Interventions for Individuals at High Risk of HIV Treatment Failure: Sequential Explorations Among Key Stakeholders in Cape Town, South Africa.
Adherence
Antiretroviral therapy adherence
Interventions
Qualitative research
Retention in care
South Africa
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
accepted:
09
02
2022
pubmed:
23
2
2022
medline:
7
7
2022
entrez:
22
2
2022
Statut:
ppublish
Résumé
To support translation of evidence-based interventions into practice for HIV patients at high risk of treatment failure, we conducted qualitative research in Cape Town, South Africa. After local health officials vetted interventions as potentially scalable, we held 41 in-depth interviews with patients with elevated viral load or a 3-month treatment gap at community clinics, followed by focus group discussions (FGDs) with 20 providers (physicians/nurses, counselors, and community health care workers). Interviews queried treatment barriers, solutions, and specific intervention options, including motivational text messages, data-informed counseling, individual counseling, peer support groups, check-in texts, and treatment buddies. Based on patients' preferences, motivational texts and treatment buddies were removed from consideration in subsequent FGDs. Patients most preferred peer support groups and check-in texts while individual counseling garnered the broadest support among providers. Check-in texts, peer support groups, and data-informed counseling were also endorsed by provider sub-groups. These strategies warrant attention for scale-up in South Africa and other resource-constrained settings.
Identifiants
pubmed: 35190943
doi: 10.1007/s10461-022-03623-7
pii: 10.1007/s10461-022-03623-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2783-2797Subventions
Organisme : Boston University School of Public Health
ID : Established Investigator Innovation Award
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
pubmed: 21767103
pmcid: 3200068
doi: 10.1056/NEJMoa1105243
Granich R, Williams B, Montaner J. Fifteen million people on antiretroviral treatment by 2015: treatment as prevention. Curr Opin HIV AIDS. 2013;8(1):41–9.
pubmed: 23188178
doi: 10.1097/COH.0b013e32835b80dd
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281–90.
pubmed: 24602844
pmcid: 4144040
doi: 10.1016/S1473-3099(13)70692-3
Montague BT, Vuylsteke B, Buve A. Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention. BMC Public Health. 2011;11:701.
pubmed: 21917178
pmcid: 3189888
doi: 10.1186/1471-2458-11-701
UNAIDS. 2018 GLOBAL HIV STATISTICS. [Accessed: December 15, 2020]. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf .
Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34–48.
pubmed: 27347270
pmcid: 4893541
doi: 10.2174/1874613601610010034
Rollins NC, Becquet R, Orne-Gliemann J, et al. Defining and analyzing retention-in-care among pregnant and breastfeeding HIV-infected women: unpacking the data to interpret and improve PMTCT outcomes. J Acquir Immune Defic Syndr. 2014;67(Suppl 2):S150–6.
pubmed: 25310122
doi: 10.1097/QAI.0000000000000355
Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV care after pregnancy among women in sub-Saharan Africa: falling off the cliff of the treatment cascade. Curr HIV/AIDS Rep. 2015;12(1):1–5.
pubmed: 25620530
pmcid: 4370783
doi: 10.1007/s11904-014-0252-6
Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008–2013. J Acquir Immune Defic Syndr. 2015;69(1):98–108.
pubmed: 25942461
pmcid: 4422218
doi: 10.1097/QAI.0000000000000553
Lifson AR, Workneh S, Hailemichael A, et al. Implementation of a peer HIV community support worker program in rural Ethiopia to promote retention in care. J Int Assoc Provid AIDS Care. 2017;16(1):75–80.
pubmed: 26518590
doi: 10.1177/2325957415614648
Fox MP, Bor J, Brennan AT, et al. Estimating retention in HIV care accounting for patient transfers: a national laboratory cohort study in South Africa. PLoS Med. 2018;15(6):e1002589.
pubmed: 29889844
pmcid: 5995345
doi: 10.1371/journal.pmed.1002589
UNAIDS. Country Factsheets: South Africa 2020. [Accessed: May 25, 2021]. Available from: https://www.unaids.org/en/regionscountries/countries/southafrica .
Lippman SA, El Ayadi AM, Grignon JS, et al. Improvements in the South African HIV care cascade: findings on 90-90-90 targets from successive population-representative surveys in North West Province. J Int AIDS Soc. 2019;22(6):e25295.
pubmed: 31190460
pmcid: 6562149
doi: 10.1002/jia2.25295
Orrell C, Cohen K, Leisegang R, et al. Comparison of six methods to estimate adherence in an ART-naive cohort in a resource-poor setting: which best predicts virological and resistance outcomes? AIDS Res Ther. 2017;14(1):20.
pubmed: 28376815
pmcid: 5379739
doi: 10.1186/s12981-017-0138-y
Katz IT, Kaplan R, Fitzmaurice G, et al. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: a retrospective cohort study. PLoS Med. 2017;14(11):e1002434.
pubmed: 29136014
pmcid: 5685472
doi: 10.1371/journal.pmed.1002434
Orrell C, Cohen K, Mauff K, et al. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70(5):495–502.
pubmed: 26218411
doi: 10.1097/QAI.0000000000000770
Haberer JE, Bwana BM, Orrell C, et al. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019;22(2):e25232.
pubmed: 30746898
pmcid: 6371013
doi: 10.1002/jia2.25232
El-Khatib Z, Ekstrom AM, Coovadia A, et al. Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa—a prospective cohort study. BMC Public Health. 2011;11:88.
pubmed: 21303548
pmcid: 3046911
doi: 10.1186/1471-2458-11-88
Haberer JE, Bwana BM, Orrell C, et al. Adherence in early versus late ART initiation in sub-Saharan Africa. Conference of Retrovirus and Opportunistic Infection (CROI); 2018 February. Boston, MA. 2020: Abstract 512; November 20.
Steegen K, Carmona S, Bronze M, et al. Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first South African National Survey. PLoS ONE. 2016;11(12):e0166305.
pubmed: 27907009
pmcid: 5132262
doi: 10.1371/journal.pone.0166305
Takuva S, Brown AE, Pillay Y, Delpech V, Puren AJ. The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90–90-90 targets. AIDS. 2017;31(4):545–52.
pubmed: 28121668
doi: 10.1097/QAD.0000000000001340
Mabunda K, Ngamasana EL, Babalola JO, Zunza M, Nyasulu P. Determinants of poor adherence to antiretroviral treatment using a combined effect of age and education among human immunodeficiency virus infected young adults attending care at Letaba Hospital HIV Clinic, Limpopo Province, South Africa. Pan Afr Med J. 2019;32:37.
pubmed: 31143342
pmcid: 6522179
doi: 10.11604/pamj.2019.32.37.17722
Gardner EM, Maravi ME, Rietmeijer C, Davidson AJ, Burman WJ. The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care. Appl Health Econ Health Policy. 2008;6(2–3):145–55.
pubmed: 19231907
pmcid: 2688446
doi: 10.1007/BF03256129
Cambiano V, Bertagnolio S, Jordan MR, Lundgren JD, Phillips A. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. J Infect Dis. 2013;207(Suppl 2):S57-62.
pubmed: 23687290
doi: 10.1093/infdis/jit111
Barth RE, Wensing AM, Tempelman HA, et al. Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa. AIDS. 2008;22(16):2210–2.
pubmed: 18832885
doi: 10.1097/QAD.0b013e328313bf87
World Health Organization, Regional Office for Africa. End HIV/AIDS by 2030. HIV/AIDS: Framework for Action in the WHO Africa Region, 2016–2020. [Accessed: November 20, 2020]. Available from: https://apps.who.int/iris/bitstream/handle/10665/259638/EndAIDS-eng.pdf;jsessionid=AE96079039DB8485094EF95E0A70B2A6?sequence=1 .
Haberer JE, Sabin L, Amico KR, et al. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017;20(1):21371.
pubmed: 28630651
pmcid: 5467606
doi: 10.7448/IAS.20.1.21371
Barnighausen T, Chaiyachati K, Chimbindi N, et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011;11(12):942–51.
pubmed: 22030332
pmcid: 4250825
doi: 10.1016/S1473-3099(11)70181-5
Chaiyachati KH, Ogbuoji O, Price M, et al. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28(Suppl 2):S187-204.
pubmed: 24849479
doi: 10.1097/QAD.0000000000000252
Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.
pubmed: 22393036
pmcid: 4044043
doi: 10.7326/0003-4819-156-11-201206050-00419
Kanters S, Park JJ, Chan K, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31–40.
pubmed: 27863996
doi: 10.1016/S2352-3018(16)30206-5
Mills EJ, Lester R, Thorlund K, et al. Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis. Lancet HIV. 2014;1(3):e104–11.
pubmed: 26424119
pmcid: 5096455
doi: 10.1016/S2352-3018(14)00003-4
Conn VS, Ruppar TM, Chan KC, et al. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015;31(1):145–60.
pubmed: 25333709
doi: 10.1185/03007995.2014.978939
Kegeles SM, Rebchook G, Tebbetts S, Arnold E, Team T. Facilitators and barriers to effective scale-up of an evidence-based multilevel HIV prevention intervention. Implement Sci. 2015;10:50.
pubmed: 25889582
pmcid: 4405833
doi: 10.1186/s13012-015-0216-2
Ssengooba F, Atuyambe L, Kiwanuka SN, et al. Research translation to inform national health policies: learning from multiple perspectives in Uganda. BMC Int Health Hum Rights. 2011;11(Suppl 1):S13.
pubmed: 21411000
pmcid: 3059472
doi: 10.1186/1472-698X-11-S1-S13
Catania JA, Dolcini MM, Harper GW, et al. Bridging barriers to clinic-based HIV testing with new technology: translating self-implemented testing for African American youth. Transl Behav Med. 2015;5(4):372–83.
pubmed: 26622910
pmcid: 4656217
doi: 10.1007/s13142-015-0331-2
Medecins Sans Frontieres Khayelitsha. Supporting Adherence to Antiretroviral Treatment: A Facility Approach to Reduce the Risk of Treatment Failure. Report and Toolkit. [Accessed: February 15, 2020]. Available from: https://www.msf.org.za/system/tdf/risk_of_treatment_failure_mentorship_toolkit_v3.pdf?file=1&type=node&id=3080 .
Dr. Beth Harley, Clinical Medical Officer, City of Cape Town. Personal communication to Dr. Catherine Orrell. November 19, 2019.
Sister Judy Caldwell, TB Programme Manager for the City of Cape Town, Cape Town City Health Management Team (HMT). Personal communication to Dr. Catherine Orrell. December 1, 2019.
Linnemayr S, Huang H, Luoto J, et al. Text messaging for improving antiretroviral therapy adherence: no effects after 1 year in a randomized controlled trial among adolescents and young adults. Am J Public Health. 2017;107(12):1944–50.
pubmed: 29048966
pmcid: 5678388
doi: 10.2105/AJPH.2017.304089
Sabin LL, DeSilva MB, Hamer DH, et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav. 2010;14(3):580–9.
pubmed: 19771504
doi: 10.1007/s10461-009-9615-1
Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.
pubmed: 21071074
doi: 10.1016/S0140-6736(10)61997-6
Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.
pubmed: 21252632
doi: 10.1097/QAD.0b013e32834380c1
Uzma Q, Emmanuel F, Ather U, Zaman S. Efficacy of interventions for improving antiretroviral therapy adherence in HIV/AIDS Cases at PIMS, Islamabad. J Int Assoc Physicians AIDS Care (Chic). 2011;10(6):373–83.
doi: 10.1177/1545109710383175
Taiwo BO, Idoko JA, Welty LJ, et al. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;54(1):85–92.
pubmed: 20418724
doi: 10.1097/01.qai.0000371678.25873.1c
Kipp W, Konde-Lule J, Saunders LD, et al. Results of a community-based antiretroviral treatment program for HIV-1 infection in Western Uganda. Curr HIV Res. 2010;8(2):179–85.
pubmed: 20163349
doi: 10.2174/157016210790442722
Chang LW, Kagaayi J, Nakigozi G, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS ONE. 2010;5(6):e10923.
pubmed: 20532194
pmcid: 2880005
doi: 10.1371/journal.pone.0010923
Mugusi F, Mugusi S, Bakari M, et al. Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Trop Med Int Health. 2009;14(10):1226–32.
pubmed: 19732408
doi: 10.1111/j.1365-3156.2009.02359.x
Green J, Thorogood N. Qualitative methods for health research. 4th ed. London: SAGE; 2017.
Pyne JM, Fortney JC, Curran GM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011;171(1):23–31.
pubmed: 21220657
Kanwal F, Pyne JM, Tavakoli-Tabasi S, et al. Collaborative care for depression in chronic hepatitis C clinics. Psychiatr Serv. 2016;67(10):1076–82.
pubmed: 27364808
doi: 10.1176/appi.ps.201400474
Pyne JM, Asch SM, Lincourt K, et al. Quality indicators for depression care in HIV patients. AIDS Care. 2008;20(9):1075–83.
pubmed: 18825515
doi: 10.1080/09540120701796884
QSR International. NVivo qualitative data analysis software. [Accessed: November 29, 2021]. Available from: http://www.qsrinternational.com/ .
Patel AR, Kessler J, Braithwaite RS, et al. Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya. Medicine (Baltimore). 2017;96(7):e6078.
doi: 10.1097/MD.0000000000006078
Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9(2):e88166.
pubmed: 24505411
pmcid: 3914915
doi: 10.1371/journal.pone.0088166
Mayer JE, Fontelo P. Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care. 2017;29(4):409–17.
pubmed: 27477580
doi: 10.1080/09540121.2016.1214674
Kalichman SC, Kalichman MO, Cherry C, et al. Randomized factorial trial of phone-delivered support counseling and daily text message reminders for HIV treatment adherence. J Acquir Immune Defic Syndr. 2016;73(1):47–54.
pubmed: 27105048
pmcid: 4981529
doi: 10.1097/QAI.0000000000001020
Kruse C, Betancourt J, Ortiz S, et al. Barriers to the use of mobile health in improving health outcomes in developing countries: systematic review. J Med Internet Res. 2019;21(10):e13263.
pubmed: 31593543
pmcid: 6811771
doi: 10.2196/13263
Ronen K, Unger JA, Drake AL, et al. SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content. AIDS Care. 2018;30(4):500–5.
pubmed: 29254362
doi: 10.1080/09540121.2017.1417971
Endebu T, Deksisa A, Dugasa W, Mulu E, Bogale T. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia. BMC Public Health. 2019;19(1):1315.
pubmed: 31638936
pmcid: 6805404
doi: 10.1186/s12889-019-7687-z
Sabin LL, Bachman DeSilva M, Gill CJ, et al. Improving adherence to antiretroviral therapy with triggered real-time text message reminders: the China adherence through technology study. J Acquir Immune Defic Syndr. 2015;69(5):551–9.
pubmed: 25886927
pmcid: 4552400
doi: 10.1097/QAI.0000000000000651
Gill CJ, Sabin LL, Hamer DH, et al. Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2010;14(4):785–93.
pubmed: 19353263
doi: 10.1007/s10461-009-9555-9
Haberer JE, Kiwanuka J, Nansera D, et al. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS ONE. 2012;7(5):e36737.
pubmed: 22590600
pmcid: 3348916
doi: 10.1371/journal.pone.0036737
Wisepill Technologies. Wisepill Technologies home page. [Accessed: December 10, 2021]. Available from: https://www.wisepill.com/ .
Information Mediary Corps. eCAP product homepage. [Accessed: August 5, 2021]. Available from: http://informationmediary.com/ecap .
Phillips AN, Cambiano V, Nakagawa F, et al. Cost effectiveness of potential ART adherence monitoring interventions in sub-Saharan Africa. PLoS ONE. 2016;11(12):e0167654.
pubmed: 27977702
pmcid: 5157976
doi: 10.1371/journal.pone.0167654
Becker N, Cordeiro LS, Poudel KC, et al. Individual, household, and community level barriers to ART adherence among women in rural Eswatini. PLoS ONE. 2020;15(4):e0231952.
pubmed: 32343742
pmcid: 7188206
doi: 10.1371/journal.pone.0231952
Schatz E, Seeley J, Negin J, et al. “For us here, we remind ourselves”: strategies and barriers to ART access and adherence among older Ugandans. BMC Public Health. 2019;19(1):131.
pubmed: 30704445
pmcid: 6357505
doi: 10.1186/s12889-019-6463-4
Kagee A, Remien RH, Berkman A, et al. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97.
pubmed: 20509066
pmcid: 3056922
doi: 10.1080/17441691003796387
Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640.
pubmed: 24242258
pmcid: 3833107
doi: 10.7448/IAS.16.3.18640
DeSilva M, Vu CN, Bonawitz R, et al. The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam. Trials. 2019;20(1):150.
pubmed: 30819228
pmcid: 6394014
doi: 10.1186/s13063-019-3239-1
Osler M, Hilderbrand K, Hennessey C, et al. A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. J Int AIDS Soc. 2014;17:18908.
pubmed: 24780511
pmcid: 4005043
doi: 10.7448/IAS.17.1.18908